Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.470
-0.030 (-2.00%)
Aug 21, 2026, 11:36 AM EDT - Market open
Enlivex Market Cap
Enlivex has a market cap or net worth of $25.7 million as of August 21, 2026. Its market cap has decreased by -1.34% in one year.
Market Cap
25.70M
Enterprise Value
20.59M
1-Year Change
-1.34%
Ranking
Category
Stock Price
$1.47
ChartMarket Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $25.70M, a decrease of -74.71%. That is a compound annual growth rate of -16.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 25.70M | -84.60% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 27.84M |
| CEL-SCI | 27.79M |
| Genenta Science | 27.60M |
| GridAI Technologies | 27.55M |
| Tevogen | 26.62M |
| Evaxion | 26.27M |
| Atossa Therapeutics | 25.85M |
| Barinthus Biotherapeutics | 25.33M |